Inhibition of the Wnt/β-catenin pathway enhances anti-tumor immunity in ovarian cancer

被引：0
|
作者：
Doo, D. W. [1 ]
Meza-Perez, S. [1 ]
Londono, A. [1 ]
Boone, J. D. [1 ]
Moore, D. J. [1 ]
Hudson, C. [2 ]
Betella, I. [1 ]
Luke, J. J. [3 ]
Yang, E. S. [1 ]
Birrer, M. J. [1 ]
Starenki, D. [4 ]
Buchsbaum, D. J. [1 ]
Norian, L. A. [1 ]
Randall, T. [1 ]
Arend, R. C. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Calif Riverside, Riverside, CA 92521 USA
[3] Univ Chicago Med, Chicago, IL USA
[4] Genet Genomics, Huntsville, AL USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.224
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1333
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
    Doo, David W.
    Meza-Perez, Selene
    Londono, Angelina, I
    Goldsberry, Whitney N.
    Katre, Ashwini A.
    Boone, Jonathan D.
    Moore, Dylana J.
    Hudson, Cindy T.
    Betella, Ilaria
    McCaw, Tyler R.
    Gangrade, Abhishek
    Bao, Riyue
    Luke, Jason J.
    Yang, Eddy S.
    Birrer, Michael J.
    Starenki, Dmytro
    Cooper, Sara J.
    Buchsbaum, Donald J.
    Norian, Lyse A.
    Randall, Troy D.
    Arend, Rebecca C.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [2] Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
    Goebel, Andy
    Zinna, Valentina M.
    Dell'Endice, Stefania
    Jaschke, Nikolai
    Kuhlmann, Jan Dominik
    Wimberger, Pauline
    Rachner, Tilman D.
    BMC CANCER, 2020, 20 (01)
  • [3] Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
    Andy Göbel
    Valentina M. Zinna
    Stefania Dell’Endice
    Nikolai Jaschke
    Jan Dominik Kuhlmann
    Pauline Wimberger
    Tilman D. Rachner
    BMC Cancer, 20
  • [4] PP4 inhibition stimulates anti-tumor immunity in ovarian cancer
    Curtis, Marion R.
    Raja, Remya
    Wu, Christopher
    Rubino, Thomas
    Utagawa, Emma
    Magtibay, Paul
    Butler, Kristina
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [5] Protein phosphatase 4 inhibition stimulates anti-tumor immunity in ovarian cancer
    Raja, Remya
    Wu, Christopher
    Bassoy, Esen Y.
    Rubino, Thomas
    Utagawa, Emma
    Magtibay, Paul
    Butler, Kristina
    Curtis, Marion
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy
    Wall, J. A.
    Meza-Perez, S.
    Scalise, C. B.
    Katre, A.
    Londono, A., I
    Turbitt, W. J.
    Randall, T.
    Norian, L. A.
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2021, 160 (01) : 285 - 294
  • [7] Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
    Lin, Hsiao-Hui
    Feng, Wen-Chi
    Lu, Li-Chun
    Shao, Yu-Yun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    CANCER LETTERS, 2016, 381 (01) : 58 - 66
  • [8] Inhibition of acetate metabolism enhances host anti-tumor immunity
    Miller, Katelyn
    Schug, Zachary T.
    CANCER RESEARCH, 2021, 81 (04)
  • [9] Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
    Arend, Rebecca C.
    Londono-Joshi, Angelina I.
    Samant, Rajeev S.
    Li, Yonghe
    Conner, Michael
    Hidalgo, Bertha
    Alvarez, Ronald D.
    Landen, Charles N.
    Straughn, J. Michael
    Buchsbaum, Donald J.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (01) : 112 - 120
  • [10] Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition
    Bi, Xiuli
    Xia, Xichun
    Mou, Teng
    Jiang, Bowen
    Fan, Dongdong
    Wang, Peng
    Liu, Yafei
    Hou, Yue
    Zhao, Yuqing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 742 : 145 - 152
12345